Clinical Trial Update: 3-Tesla MRI Response to TACE in HCC (Liver Cancer) [NA]

View source ↗

Summary

Clinical trial update noting 3-Tesla MRI responses to transarterial chemoembolization in hepatocellular carcinoma, with the study terminated and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | NA | Status: TERMINATED | Results posted: 2018-07-11